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Lipid accumulation is the hallmark of Non-alcoholic Fatty Liver Disease (NAFLD) and has been suggested
to play a role in promoting fatty liver inflammation. Previous findings indicate that during oxidative
stress conditions excess cholesterol autoxidizes to oxysterols. To date, the role of oxysterols and their
potential interaction with fatty acids accumulation in NASH pathogenesis remains little investigated.
We used the nutritional model of high fatty acids (HFA), high cholesterol (HCh) or high fat and high
cholesterol (HFAþFCh) diets and explored by a lipidomic approach, the blood and liver distribution of
fatty acids and oxysterols in response to dietary manipulation. We observed that HFA or HCh diets in-
duced fatty liver without inflammation, which was otherwise observed only after supplementation of
HFAþHCh. Very interestingly, the combination model was associated with a specific oxysterol finger-
print.
The present work provides a complete analysis of the change in lipids and oxysterols profile induced
by different lipid dietary model and their association with histological alteration of the liver. This study
allows the generation of interesting hypotheses on the role of interaction of lipid and cholesterol me-
tabolites in the liver injury during NAFLD development and progression. Moreover, the changes in the
concentration and quality of oxysterols induced by a combination diet suggest a novel potential pa-
thogenic mechanism in the progression from simple steatosis to steatohepatitis.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).B.V. This is an open access article
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.1. Introduction
Nonalcoholic fatty liver disease (NAFLD), the most common
liver pathology in the Western world [1], covers diverse clinical
conditions ranging from benign steatosis (NAFL), steatohepatitis
(NASH) – the most progressive form of the disease [2] – through
liver cirrhosis. The transformation from non-inflamed to inflamed
fatty liver is transient and the underlying mechanisms are not yet
elucidated. Potential candidates include alteration in lipid meta-
bolism, mitochondrial dysfunction, inflammation, and oxidative
stress [3–6].
Accumulation of lipids in hepatocytes, the hallmark of NAFLD,
is not necessarily dangerous because liver injury is caused by the
quality rather than quantity of accumulated lipids. In NAFL, large
amounts of triglycerides are accumulated in hepatocytes without
harm (8–10). Lipotoxicity defines cellular injury caused by specificunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(FA) and cholesterol-related species.
By using a nutritional model of NAFLD in rat, Matsuzawa et al.
[8] showed that the association of a high cholesterol and high FA
diet, but not one of them given alone, favored the development of
steatohepatitis. These findings indicate that the two lipid species
work together in combination in the pathogenesis of
steatohepatitis.
Specific FA are important mediators of hepatic lipotoxicity in-
volving multiple mechanisms that activate lysosomal- and mi-
tochondrial-dependent apoptotic pathways, as well as the en-
doplasmic reticulum stress [9,10]. On the other hand, certain FA
are harmless to the liver. In particular, supplementation of the
monounsaturated FA oleic acid leads to safe triglycerides (TG)
accumulation in liver cells, while palmitic acid, a saturated fatty
acid (SFA), in the same conditions causes apoptosis (8). Similar
results can be obtained by manipulating combination of oleic acid
and palmitic acid in specific ratios [11].
Excess cholesterol, a leading risk factor in cardiovascular dis-
eases (14), reportedly induce hepatocellular sensitivity to in-
flammatory mediators [12]. Cholesterol autoxidize to diverse
molecules, namely oxysterols, under inflammatory and up-regu-
lated oxidative stress conditions that occurs in the context of liver
injury. Having shown potent bioactive properties, oxysterols have
been suggested to play a role in NAFLD pathogenesis [13,14]. Also,
oxysterols can be generated enzymatically by cytochrome (CYP)
family enzymes, including those channeling oxysterols into the
bile acid pathway, whose expression can be altered during liver
insult [14,15].
However, the role of oxysterols and their potential interaction
with the FA system in NASH remain little investigated.
In the present work we studied liver damage in rats fed high
lipid diets, focusing on supplementation of high FA (HFA), high
cholesterol (HCh) or the combination of HFA and HCh enriched
diets. We used a lipidomic approach to investigate the distribution
of cholesterol, TG, FA, and oxysterols in the liver and in blood in
response to the different dietary manipulation.
We observed that HFA or HCh diets induced fatty liver without
inflammation and injury, which is otherwise observed after sup-
plementation of HFA plus HCh diet. This diet induced also the
highest level of lipid accumulation in the liver, and resulted in a
distinct oxysterol fingerprint.2. Materials and methods
2.1. Animals and experimental design
All animals received care in compliance with the Principles of
Laboratory Animal Care formulated by the National Society for
Medical Research and the guide for the Care and Use of Laboratory
Animals prepared by the Institute of Laboratory Animal Resources
(NIH Publication No. 86-23, revised 1985), as well as with Eur-
opean Directive on animal experimentation (EU Directive 2010/63/
EU for animal experiments).
Male Wistar rats (Harlan Laboratories, San Pietro al Natisone,
Italy), 8 weeks old, were housed in colony cages with a 12 h light/
12 h dark cycle, and they were fed chow ad libitum for 6 weeks.
Rats were then allocated into four dietary groups: control (CTRL,
n¼5), rats were fed chow; HFA (n¼5), rats fed high FA (60% cocoa
butter); HCh (n¼5), rats fed high-cholesterol diet (1.25% choles-
terol); and HFAHCh (n¼5), rats fed the combination of high FA
and high cholesterol (60% cocoa butter þ1.25% cholesterol). The
diets were prepared by Mucedola Srl (Settimo Milanese, Italy)
according to the levels of components previously reported [8].
Rats were weekly weighted, the amount of chow consumedand the calories introduced were estimated. At the end of the
study (6 weeks), animals were anesthetized (100 mg/kg ketamine
and 2.5 mg/kg acepromazine i.p.) and then sacrificed, serum and
liver harvested. Sections of formalin-fixed, paraffin-embedded
samples were stained with haematoxylin/eosin and blinded ana-
lyzed by light microscopy for NAFLD activity score [16]. Serum was
assayed for alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) activity, glucose, total cholesterol, HDL choles-
terol, and triglycerides, using standard kits (Sigma Aldric, Milan,
Italy).
2.2. Fatty acids measurement
Before analysis, hepatic FA were processed for direct transes-
terification with acetyl chloride according to previously published
methods [17,18], which allowed for the derivatization of both free
and esterified FA as methyl esters. Analyses were performed on an
Agilent 7820 A Plus Gas Chromatograph (Agilent Technologies)
equipped with a G4513A automatic liquid sampler and a flame-
ionization detector. Separation was carried out on a 100-m capil-
lary column (Supelco, SP-2560 100 m0.25 mm inner diameter,
0.20 mm thickness; Sigma Aldrich, Milan, Italy). Identification,
precision, and accuracy were evaluated by using mixtures of au-
thentic methylated free FA (FFA) standards and a control pool as
previously described [19]. Fatty acids are expressed as the per-
centage of total fatty acids. An overview of the saturated, mono-
unsaturated, and polyunsaturated fatty acids measured is depicted
in Table 1.
2.3. Oxysterols measurement
7α-hydroxycholesterol (7α-OHC), 7β-hydroxycholesterol (7β-
OHC), 27-hydroxycholesterol (27-OHC), 25-hydroxycholesterol
(25-OHC), 4β-hydroxycholesterol (4β-OHC), 5β,6β-epox-
ycholesterol (5β,6β-epoxy), 5α,6α-epoxycholesterol (5α,6α-
epoxy), 5α-cholestane-3β,5,6β-triol (triol), 7-ketocholesterol (7-
KC) and 6-oxo-cholestan-3β,5α-diol (6-oxo) by mass spectrometry
with isotope-dilution methods, as previously reported [20]. Mo-
lecular structure is reported in Fig. 1.
2.4. Gene expression analysis by real-time RT-PCR
Real-time RT-PCR was performed on RNA extracted from liver
tissue, using SYBR Green I assay in Bio-Rad iCycler detection sys-
tem as previously reported [21]. A PCR master mix containing the
specific primers shown in Supplementary Table 1 was used. The
threshold cycle (CT) was determined, and the relative gene ex-
pression subsequently was calculated as follows: fold change
¼2Δ(ΔCT), where ΔCT¼CTCT target housekeeping and Δ
(ΔCT)¼ΔCTCT treated control.
2.5. Western blot analysis
50 mg proteins from liver homogenates were loaded in a 10%
SDS-PAGE and transferred to a nitrocellulose membrane, blocked
for 1.5 h using 5% non-fat dry milk in TBS-t and incubated over-
night at 4 °C with the following primary antibodies: mouse anti-
ABC1 (sc-58219), mouse anti-ABCG5 (sc-517207), rabbit anti-
ABCG8 (sc-30111), mouse anti-CYP7A1 (sc-293193), mouse anti-
CYP27A1 (sc-393222), rabbit anti-HMGCoA-Reductase (sc-33827),
mouse anti-SREBP-2 (sc-271616), mouse anti-FAS (sc-55580), all
purchased from Santa Cruz Biotechnology, Heidelberg, Germany).
Then, the membrane was incubated for 1.5 h with a rabbit HRP-
conjugated anti-mouse or a goat HRP-conjugated anti-rabbit sec-
ondary antibody (Bio-Rad Laboratories Inc, Segrate (MI), Italy).
Bands were detected by the Clarity™ Western ECL Blotting
Table 1
An overview of the fatty acid profile analyzed in the study. Both the trivial and the
IUPAC names are reported, together with the short-hand nomenclature, which
designates the fatty acid carbon chain length and the number of double bonds. Of
the polyunsaturated fatty acids, linoleic acid and α-linolenic acid are also known as
essential fatty acids because they are necessary and cannot be synthesized in the
body.
Abbreviation Trivial name International Union of Pure and
Applied Chemistry name
C14:0 Myristic acid Tetradecanoic acid
C16:0 Palmitic acid Hexadecanoic acid
C18:0 Stearic acid Octadecanoic acid
C20:0 Arachidic acid Icosanoic acid
C22:0 Behenic acid Docosanoic acid
C24:0 Lignoceric acid Tetracosanoic acid
C26:0 Cerotic acid Hexacosanoic acid
C14:1n-5 Myristoleic acid (9Z)-Tetradec-9-enoic acid
C16:1n-7 Palmitoleic acid (9Z)-Hexadec-9-enoic acid
C18:1n-7 Vaccenic acid (11Z)-Octadec-11-enoic-acid
C18:1n-9 Oleic acid (9Z)-Octadec-9-enoic acid
C20:1n-9 Gondoic acid (11Z)-Eicos-11-enoic acid
C22:1n-9 Erucic acid (13Z)-Docos-13-enoic acid
C24:1n-9 Nervonic acid (15Z)-Tetracos-15-enoic acid
C18:2n-6 Linoleic acid (9Z,12Z)-Octadeca-9,12-dienoic acid
C18:2n-6 γ-linolenic acid (6Z,9Z,12Z)-Octadeca-6,9,12-trienoic
acid
C20:2n-6 Eicosadienoic acid (11Z,14Z)-Icosa-11,14-dienoic acid
C20:3n-6 Dihomo-γ-linolenic
acid
(8Z,11Z,14Z)-Icosa-8,11,14-trienoic
acid
C20:4n-6 Arachidonic acid (5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetra-
enoic acid
C22:2n-6 Docosadienoic acid (13Z,16Z)-Docosa-13,16-dienoic acid
C22:4n-6 Adrenic acid (7Z,10Z,13Z,16Z)-Docosa-7,10,13,16-
tetraenoic acid
C22:5n-6 Osbond acid (4Z,7Z,10Z,13Z,16Z)-Docosa-
4,7,10,13,16-pentaenoic acid
C18:3n-3 α-linolenic acid (9Z,12Z,15Z)-octadeca-9,12,15-trienoic
acid
C20:3n-3 Eicosatrienoic acid (11Z,14Z,17Z)-eicosa-11,14,17-trienoic
acid
C20:5n-3 Eicosapentaenoic acid (5Z,8Z,11Z,14Z,17Z)-eicosa-
5,8,11,14,17-pentaenoic acid
C22:5n-3 Docosapentaenoic acid (7Z,10Z,13Z,16Z,19Z)-docosa-
7,10,13,16,19-pentaenoic acid
C22:6n-3 Docosahexaenoic acid (4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-
4,7,10,13,16,19)-hexaenoic acid
C20:3n-9 Mead acid (5Z,8Z,11Z)-Eicosa-5,8,11-trienoic acid
C18:1n-9t Elaidic acid (9E)-Octa-9-decenoic acid
C18:2n-6t Linoleadic acid (9E,12E)-octadeca-9,12-dienoic acid
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Segrate (MI), Italy) andquantified by the Image Lab™ Software.
2.6. Statistical analysis
The data were normally distributed and were expressed as
mean7standard deviation of the mean (SDM). Differences be-
tween the groups were determined by one-way analysis of var-
iance (ANOVA) with Tukey-Kramer as post hoc test. Statistical
significance was accepted when Po0.05. The GraphPad Prism
6.0 Software was used to perform the analysis.3. Results
3.1. Cholesterol and TG accumulate in serum and liver in association
with the development of steatohepatitis
Rats from HFA and HFAþHCh groups consumed lower amount
of food, compared to CTRL and HCh groups (Fig. 2A); however the
calories intake was similar (Fig. 2B). The liver to body weight ratiowas significantly increased only in HFAþHCh diet (Fig. 2C).
Compared to CTRL group, serum liver enzyme levels, including
AST, ALT and ALP, resulted significantly higher in HFAþHCh group
but not in HFA group, whereas HCh showed significantly altered
levels of AST only (Table 2). Liver histology showed massive stea-
tosis but minimal lobular inflammation in HFA group; the liver of
rats fed with HCh showed cellular ballooning and steatosis, and
mild inflammation; while the liver of HFþHCh group exhibited
macrovesicular steatosis, severe hepatocyte ballooning and diffuse
lobular infiltration (Fig. 3, Table 3).
Serum cholesterol and LDL-cholesterol were higher in HCh and
HFAþHCh groups, and TG was higher in HFA group compared to
CTRL. The accumulation of TG in serum observed in HFA group was
not observed in HFAþHCh group (Table 4). Concerning cholesterol
and TG levels in the liver, both lipids accumulated in the liver of
HFA and HFAþHCh groups, and cholesterol but not TG accumu-
lated in the liver of HCh group (Table 4).
3.2. Liver FA profiling
The total level of SFA accumulated in the liver was comparable
in HFA and HFþHC group but was significantly lower in HCh,
compared to controls. Looking at the distribution of the different
SFA accumulated in the liver, we observed a dramatic increase in
eicosanoic (20:0) and lignoceric (24:0); and a reduction in doc-
osanoic (22:0) and cerotic acid (26:0) levels in HFA and HFAþHC
dietary groups, compared to CTRL (Fig. 4).
The total amount of monounsaturated FA (MUFA) accumulated
in the liver was larger in all three dietary regimens, compared to
chow, with a consistent accumulation of oleic acid (18:1 n-9 cis).
The liver of HFA and HFAþHCh groups showed reduced levels of
palmitoleic (16:1 n-7 cis) and gadoleic acid (20:1 n-11 cis). An al-
tered pattern of MUFA was also observed in HCh fed rats, com-
pared to chow, with increased levels of palmitoleic and gadoleic
acid (Fig. 5).
The total amount of polyunsaturated FA (PUFA) was reduced in
all three dietary regimens, compared to chow. In HFA, higher le-
vels of gamma-linolenic (18:2n-6 cis), adrenic (22:4n-6 cis) and
docosapentanoic acid (22:5n-3 cis), contrasted with lower levels of
eicosadienoic (20:2n-6 cis), docosadienoic (22:2n-6 cis) and ara-
chidonic acid (20:4n-6 cis). In the liver of HFAþHCh the dis-
tribution of ω-6 FA was similar to that of HFA diet, but with lower
levels of linoleic acid (18:2n-6 cis). In HCh diet ω-6 profiling re-
vealed a reduction in gamma-linolenic (18:2n-6 cis), eicosadienoic
(20:2n-6 cis) and docosadienoic acid (22:2n-6 cis).
Concerning PUFA of ω-3 series, a lower content of linolenic acid
(18:3n-3 cis), eicosatrienoic acid (20:3n-3 cis), eicosapentaenoic
acid (20:5n-3 cis) and docosapentaenoic acid (22:5n-3 cis) was
observed in HFA group; eicosapentaenoic acid (20:5n-3 cis) and
docosahexaenoic acid (22:6n-3 cis) were reduced in HFAþHCh
group, and a significant increase in eicosapentaenoic acid (20:5n-3
cis) was observed in HCh group.
All groups showed accumulation of mead acid (20:3n-9 cis).
Trans-FA elaidic acid (18:1n-9 trans) was reduced in HCh and
HFþHCh groups, and linoleaidic acid (18:2n-9 trans) was reduced
in all three dietary groups, compared to chow (Fig. 6).
3.3. Liver oxysterol profiling
No significant changes in liver oxysterol content was observed
in response to HFA diet, with exception of reduced levels of 4β-
hydroxycholesterol. HCh diet induced accumulation of 7α-, 7β-,
4β-, 25-hydroxycholesterol, 7-ketocholesterol, and triol. This pat-
tern was not conserved in the combined high lipid diets
(HFAþHCh), in that 4β-hydroxycholesterol unchanged and 5α,6α-
and 5β,6β-epoxides were reduced compared to chow (Fig. 7).
Fig. 1. Molecular structure of oxysterols analyzed. Blue lines identify oxysterols of enzymatic origin; red lines identify putative autoxidation oxysterols. For interpretation of
the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 2. Chow consumed per week (panel A), calories intake (panel B) r weight ratio (panel C) in rats fed standard chow (CTRL), high-fat (HFA), high-cholesterol (HCh) and
high-fatþhigh-cholesterol (HFAþHCh) diet for 6 weeks. Data are expressed as mean7SDM. Statistical differences were assessed by one-way ANOVA and Tukey-Kramer as
post-hoc test. *¼po0.05 vs CTRL and HFA groups;**¼po0.01 vs CTRL and HFA groups.
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and fatty acid synthesis
Cholesterol oxidation involves several mono-oxygenation re-
actions, which are catalyzed by cytochromes P450 (CYPs). During
normal hepatic cholesterol degradation, cholesterol can be en-
zimatically converted to 7α-hydroxycholestrol (7α-OHC) by 7α-
hydroxylase (CYP7A1). Other CYPs such as 27-hydroxylase
(CYP27A1), 25-hydroxylase (CYP25A1) and 4β-hydroxylase(CYP3A1) catalyze the formation of the oxysterol species 27-hy-
droxycholesterol (27-OHC), 25-hydroxycholesterol (25-OHC) and
4β-hydroxycholestrol (4β-OHC), respectively. Both 7α-OHC and
27-OHC are the first intermediates in the biosynthesis of bile acids
[13]; however, while 7α-OHC initiates the canonical pathway, 27-
OHC is the first product of the alternative pathway for bile acids
synthesis [13].
Overexpression of CYP7A1 accounted for the increased 7α-OHC
concentration observed in HCh and HFAþHCh diets whereas
Table 2
Serum aminotransferases from rats fed a standard (CTRL), high-fat (HFA), high-
cholesterol (HCh) or high-fatþhighcholesterol (HFAþHCh) diet. AST, aspartate
aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase. Data
are expressed as mean7SDM. Statistical differences were assessed by one-way
ANOVA and Tukey-Kramer as post-hoc test. *,**,***¼po0.05, 0.01, 0.001 vs CTRL; ,^ ,^
^¼p o0.05, 0.01, 0.001 vs HFA; #, ##, ###¼po0.05, 0.01, 0.001 vs HCh.
CTRL HFA HCh HFAþHCh
Serum AST
(U/L)
48.0.7 2.9 54.671.7 218.5790.9*,^ 428.07106.1**,^,#
Serum ALT
(U/L)
47.076.2 44.679.9 137.87102.1 389.77147.1*,^
Serum ALP
(U/L)
198.07104.1 212.4771.4 186.5.754.7 452.07104.9*,^,##
Fig. 3. Histological analysis of representative liver samples from rats fed a standard
(CTRL), high-fat (HFA), high-cholesterol (HCh) or high-fatþhigh-cholesterol
(HFAþHCh) diet for 6 weeks, stained with Haematoxilin & Eosin (magnification
200x).
Table 3
Kleiner scoring system applied to liver samples from rats fed a standard (CTRL),
high-fat (HFA), high-cholesterol (HCh) or high-fatþhighcholesterol (HFAþHCh)
diet.
CTRL HFA HCh HFAþHCh
Steatosis 0 3 1 2
Ballooning 0 0 3 2
Lobular inflammation 0 1 1 2
Activity score 0 4 5 6
Indication Normal NAFL NASH NASH
Table 4
Serum biochemistry and liver lipids content from rats fed a standard (CTRL), high-fat (
aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase. D
ANOVA and Tukey-Kramer as post-hoc test. *,**,***¼po0.05, 0.01, 0.001 vs CTRL; ,^ ,^ ^¼
CTRL HF
Serum Glucose (mg/dL) 157.7741.1 19
Serum Total Cholesterol (mg/dL) 64.074.6 59
Serum LDL-Cholesterol (mg/dL) 20.073.6 7.7
Serum Triglycerides (mg/dL) 55.0714.1 92
Hepatic Triglycerides (lg/mg prot) 65.3714.2 13
Hepatic Total Cholesterol (lg/mg prot) 40.974.4 16
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When cholesterol accumulates in the hepatocytes, proteins
deputed to cholesterol secretion such as ABCA1, ABCG5 and
ABCG8 are activated. In fact, we observed up-regulation of such
proteins in cholesterol containing diets.
In the HFA diet we observed activation of the cholesterol
synthesis (increased HMG-CoA reductase and SREBP2 expression)
that was not observed in HCh diet where synthesis of fatty acids
was up-regulated. Interestingly, both cholesterol and fatty acids
synthesis, that are part of the strategy to limit accumulation of
FFAs and cholesterol, did not activate in the combination diet
(Figs. 8 and 9).4. Discussion
NAFLD is characterized by altered lipid homeostasis, but there
is little data on the potential interaction of various lipid classes. i.e.
fatty acids and cholesterol metabolism, during NAFLD develop-
ment and progression. Puri et al. reported that FFA content in the
liver remains unaltered during NAFLD development despite an
increase in the total lipid content [22]. They also observed a pro-
gressive increase in free cholesterol and a decrease in phospholi-
pid content during disease evolution, from simple steatosis
through NASH, suggesting a complex interaction among different
lipids in the pathogenesis of liver metabolic disease.
From the first observation of Matsuzawa reporting that the
combination of FA and cholesterol in a high lipid diet is associated
with the induction of steatohepatitis [8], nutritional models have
been proposed to explore the complex change occurring not only
in the amount but rather in the quality of different lipotoxic pro-
ducts during steatohepatitis progression. A novel and intriguing
role has been suggested for the oxidative products of cholesterol,
namely oxysterols, which are produced by enzymatic mechanisms
or by autoxidation [23,24]. However, so far no information have
been provided on the “cholesterol side” of the lipid changes in-
duced by different hyper-lipidic diets.
Based on standardized animal models, we provide evidence
that specific histological modifications in the liver, observed with
different lipid diets, associate with altered FFAs and oxysterols
profile. Our data confirm previous observation that high fat diet
induces only a non-progressive steatosis due to triglycerides ac-
cumulation whereas high cholesterol diet causes hepatocyte bal-
looning due to cholesterol accumulation. Importantly, only the
combination of cholesterol and fatty acids in the high lipid diet
resulted steatosis, cellular ballooning and inflammation.
The HFA-HCh diet was associated with significant differences in
the composition of saturated, monounsaturated and poly-
unsaturated fatty acids content in the liver. In particular, even
though the total level of SFAs was similar to the controls – as oc-
curring in human pathology [22,25] – long chain SFAs accumulated
in high fat-based diets but not in the high cholesterol alone.HFA), high-cholesterol (HCh) or high-fatþhighcholesterol (HFAþHCh) diet. AST,
ata are expressed as mean7SDM. Statistical differences were assessed by one-way
po0.05, 0.01, 0.001 vs HFA; #, ##, ###¼po0.05, 0.01, 0.001 vs HCh.
A HCh HFAþHCh
3.7750.1 155.3750.1 116.3714.8
.0712.2 195.0730.5***,^ 195.5732.9***,^
72.9 146.279.8***,^ 100.0710.9***,^
.3714.0* 62.0714.7 66.079.3
2.3721.3**,# 90.2720.3 152.9719.9***,##
2.3724.5*** 190.7730.2*** 332.4739.1***,^,###
Fig. 4. Levels of saturated fatty acids (SFAs, panel A) and complete SFAs profile (panel B) in the liver of rats fed high-fat (HFA), high-cholesterol (HCh) and high-
fatþhighcholesterol (HFAþHCh) diet for 6 weeks. Statistical differences were assessed by one-way ANOVA and Tukey-Kramer as post-hoc test (panel A) or by student's t-
test versus the control group (panel B). *,**,***¼po0.05, 0.01, 0.001 vs CTRL; ,^ ,^ ^¼po0.05, 0.01, 0.001 vs HFA; #, ##, ###¼ po0.05, 0.01, 0.001 vs HCh.
Fig. 5. Levels of monounsaturated fatty acids (MUFAs, panel A) and complete MUFAs profile (panel B) in the liver of rats fed high-fat (HFA), high-cholesterol (HCh) and high-
fatþhighcholesterol (HFAþHCh) diet for 6 weeks. Statistical differences were assessed by one-way ANOVA and Tukey-Kramer as post-hoc test (panel A) or by student's t-
test versus the control group (panel B). *,**,***¼po0.05, 0.01, 0.001 vs CTRL; ,^ ,^ ^¼po0.05, 0.01, 0.001 vs HFA; #, ##, ###¼po0.05, 0.01, 0.001 vs HCh.
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Fig. 6. Levels of polyunsaturated fatty acids (PUFAs, panel A) and complete PUFAs profile (panel B) in the liver of rats fed high-fat (HFA), high-cholesterol (HCh) and high-
fatþhighcholesterol (HFAþHCh) diet for 6 weeks. Statistical differences were assessed by one-way ANOVA and Tukey-Kramer as post-hoc test (panel A) or by student's t-
test versus the control group (panel B). *,**,***¼po0.05, 0.01, 0.001 vs CTRL; ,^ ,^ ^¼po0.05, 0.01, 0.001 vs HFA; #, ##, ###¼po0.05, 0.01, 0.001 vs HCh.
G. Serviddio et al. / Redox Biology 9 (2016) 296–305302The FA and cholesterol dietary content also impacted in the
composition of hepatocytes lipids in terms of MUFA and PUFA; even
though MUFA increased in the HFA and HFAþHCh diets, we ob-
served only a significant increase in the oleic acid level, the most
abundant MUFA, whereas palmitoleic (16:1n-7) and gadoleic
(20:1n-11) acids increased only in the cholesterol diet. The analysis
of PUFA showed that ω-6 was lower in high fat based diets as
compared to cholesterol diet whereas change in the ω-3 amount
was less evident. Very interestingly, arachidonic acid (20:4n-6) was
reduced in the high fat group while it was highly variable in the
combination diet and associated with a reduction of n-6 precursor
(linoleic acid). Eicosapentaenoic acid (20:5n-3) andFig. 7. Oxysterol profile in the liver of rats fed high-fat (HFA), high-cholesterol (HCh) an
mean 7 SDM of the percentage relative to the levels of rats fed the standard chow
hydroxycholesterol; 7β-OHC, 7β-hydroxycholesterol; 27-OHC, 27-hydroxycholesterol; 25
epoxycholesterol; 5β,6β-epoxy, 5β,6β-epoxycholesterol; triol, 5α-cholestane-3β,5,6β-trioldocosahexaenoic acid (22:6n-3) were also reduced in HFA and
HFAþHCh diets but not in the HCh diet. The reduction of n-3
precursor and the increase in mead acid (20:3n-9) level, particularly
in the combination diet, indicate that this is not due to a deficiency
in availability of essential fatty acids (EFAs) but rather to an in-
efficiency in the conversion of these precursor EFAs to downstream
ω-3 and ω-6 fatty acids, in good agreement with the observation in
man [22]. Our data also suggest that high fat diet induces a different
regulation of the desaturation index (lower palmitoleic/palmitic
and higher oleic/stearic), probably related to increased chain elon-
gation [26]. The control of desaturase signaling and the role played
in the liver injury merit further investigations.d high-fatþhighcholesterol (HFAþHCh) diet for 6 weeks. Data are expressed as
(CTRL). Statistical differences were assessed by the student's t-test. 7α-OHC, 7α-
-OHC, 25-hydroxycholesterol; 4β-OHC, 4β-hydroxycholesterol; 5α,6α-epoxy, 5α,6α-
; 7-KC, 7-ketocholesterol; 6-oxo, 6-oxo-cholestan-3β,5α-diol.
Fig. 8. Expression levels of genes involved in cholesterol and fatty acids metabolism in the liver of rats fed standard chow (CTRL), high-fat (HFA), high-cholesterol (HCh) and
high-fatþhighcholesterol (HFAþHCh) diet for 6 weeks. Data are expressed as mean7SDM of the percentage of the fold change expression related to CTRL. Statistical
differences were assessed by one-way ANOVA and Tukey-Kramer as post-hoc test. *,**¼po0.05, 0.01 vs CTRL; ^¼po0.05 vs HFA.
G. Serviddio et al. / Redox Biology 9 (2016) 296–305 303Even more intriguing are the results of oxysterol profile. Oxy-
sterols are metabolites of cholesterol that are produced in the liver
and other peripheral tissues as a means to eliminate cholesterol to
bile acid. During normal hepatic cholesterol degradation, choles-
terol can be enzimatically converted to 7α-hydroxycholesterol
(7α-OHC) by 7α-hydroxylase (CYP7A1). Our data show that in the
high cholesterol based diets 7α-OHC dramatically increased as a
consequence of overexpression of CYP7A1 that is the main reg-
ulator of the canonical pathway of bile acids synthesis (16). On the
contrary, other CYPs such as 27-hydroxylase (CYP27A1), 25-hy-
droxylase (CYP25A1) and 4β-hydroxylase (CYP3A1) catalyze the
formation of 27-hydroxycholesterol (27-OHC) (the most abundant
circulating oxysterol), 25-hydroxycholesterol (25-OHC) and 4β-
hydroxycholesterol (4β-OHC), respectively. Both 7α-OHC and 27-
OHC are the first intermediates in the biosynthesis of bile acids
[13]; however, while 7α-OHC initiates the canonical pathway, 27-
OHC is the first product of the alternative pathway for bile acids
synthesis [13]. In human NASH, it has been reported a shift from
the canonical to the alternative bile acids synthesis pathway as a
mechanism to limit hepatotoxicity of cholesterol [27]. It is worth
to note that the alternative pathway becomes more predominant
and compensates for limitations of the classical pathway during
liver disease [28]. Here, we observed an increase of 7α-OHC, to-
gether with a higher expression of Cyp7a1, in the liver of high
cholesterol diets, while no modifications occurred for 27-OHC
concentration and Cyp27a1 expression. Accordingly, the excessdietary cholesterol induced activation of the canonical but not the
alternative pathway of bile acids synthesis.
25-OHC reportedly acts as a signal to suppress cholesterol
synthesis through the degradation of SREBPs and HMG-CoA re-
ductase [29]. Our data show that, during high fat diet, fatty acids
synthesis is inhibited and cholesterol synthesis is conserved as a
mechanism of fatty acids elimination. In high cholesterol diet, Fas
is overexpressed and cholesterol synthesis inhibited to shift cho-
lesterol accumulation toward fatty acids; in the combination diet,
both Fas and Hmg-CoA reductase are inhibited: as a consequence,
both fatty acid and cholesterol excess cannot be eliminated.
Cholesterol can be alternatively subjected to nonenzymatic
autoxidation, which leads to the formation of a number of cho-
lesterol oxidation products, including 7-ketocholesterol (7-KC),
7β-hydroxycholesterol (7β-OHC), 5α,6α-epoxycholesterol (5α,6α-
epoxy), 5β,6β-epoxycholesterol (5β,6β-epoxy), 5α-cholestane-
3β,5,6β-triol (triol), and 6-oxo-cholestan-3β,5α-diol (6-oxo). The
modification in the metabolic pathway associated with different
oxysterol profile: in the HF diet, enzymatic oxysterols were un-
changed and among the non-enzymatic, epoxides levels were
conserved with an increase in Triol and 6-oxo; in the high-cho-
lesterol diet the non-enzymatic 7-KC and 7β-OHC increase dra-
matically together with 25-OHC, 4β-OHC and 7α-OHC as possible
signaling strategy to eliminate cholesterol excess. In the combi-
nation diet, 4β-OHC was unchanged and epoxides were low as
compared to HCh and HFA diet: this probably accounted, almost in
Fig. 9. Representative blots (panel A) and relative densitometric analysis (panel B) of proteins involved in cholesterol and fatty acids metabolism in the liver of rats fed
standard chow (CTRL), high-fat (HFA), high-cholesterol (HCh) and high-fatþhighcholesterol (HFAþHCh) diet for 6 weeks. Data are expressed as mean7SDM. Statistical
differences were assessed by one-way ANOVA and Tukey-Kramer as post-hoc test. *,**¼po0.05, 0.01 vs CTRL; ^¼po0.05 vs HFA.
G. Serviddio et al. / Redox Biology 9 (2016) 296–305304part, for the inefficient cholesterol and fatty acid elimination. Since
the accumulation of 4β-OHC may activate inflammation, this may
explain mild inflammation in HC livers as compared to HF [30].
The dietary cholesterol excess leads to increased hepatic levels
of 7β-OHC and 7-KC, as reported in both the HCh and the
HFAþHCh groups. Since such compounds are considered cytotoxic
and pro-apoptotic [13], we hypothesize that their accumulation in
the liver, together with FFAs, might take part in the pathogenic
mechanism of the transition from simple steatosis to
steatohepatitis.
The role of epoxides is under active investigation since the for-
mation of 5β,6β-epoxy has been observed previously as a result of
cholesterol peroxidation and autoxidation [31]. This oxysterol was
shown to initiate cellular apoptosis in several systems and to play a
role in lipid loading of macrophages [32–34]. Moreover, their role
has been previously suggested in the damage of lung epithelial cells
exposed to ozone [35]. Both 5β,6β-epoxy and 6-oxo are potent in-
hibitors of cholesterol synthesis from acetate, a pathway that in-
volves numerous steps and several intermediates. Such oxysterols
may interfere with the prenylation of proteins, and it has been
suggested that blocking protein prenylation can cause changes in
inflammatory signaling [36]. The reason why in the combination
diet the level of β-epoxides decreases is not known, but their ca-
pacity to inhibit cholesterol synthesis suggests a possible role in the
hepatic injury induced by cholesterol accumulation.
The present study was performed on male Wistar rats and
conclusions cannot be generalized to female; this may be a pos-
sible limitation, since a genre difference in dietary lipid manip-
ulation may exist, in particular this is valid for metabolic syndrome
in humans [37].In conclusion, the present work provides a complete analysis of
the change in lipids and oxysterols profile induced by different
lipid dietary model and their association with histological altera-
tion of the liver. Even though the biological implications of the
reported changes in the lipid composition are complex and diffi-
cult to predict simply on the basis of lipidomic data, the present
study allows the generation of interesting hypotheses on the role
of interaction of lipid and cholesterol metabolites in the liver in-
jury during NAFLD development and progression. Moreover, the
changes in the concentration and quality of oxysterols induced by
a combination diet suggest a novel potential pathogenic me-
chanism in the progression from simple steatosis to
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